Back to search

Japan· JP-6349802X1020

フィブリノゲン配合剤

A medicinal product containing フィブリノゲン配合剤, registered in Japan by CSLベーリング, on the national reimbursement list.

On Japan’s NHI price list

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedフィブリノゲン配合剤ATC—REGISTER NO.JP-6349802X1020PACKS LISTED0CHECKEDSeptember 25, 2026

The record

At a glance

MHLW / PMDA (Japan)
Active substance
フィブリノゲン配合剤
Manufacturer
CSLベーリング
Country
Japan (JP)
ATC code
—
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

フィブリノゲン配合剤 in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All フィブリノゲン配合剤 products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Fibclot, Fibryga
  • Belgium · Fibclot, Fibryga
  • Bulgaria · Fibryga, Хемокомплетан P
  • Cyprus · Fibryga, Riastap
  • Czechia · Fibryga, Haemocomplettan P
  • Germany · Fibclot, Fibryga
  • Denmark · Fibclot, Fibryga
  • Estonia · Fibryga
  • Spain · Fibclot, Fibryga
  • Finland · Fibclot, Fibryga
  • France · Clottafact, Fibryga
  • United Kingdom (Northern Ireland) · Fibclot, Fibryga
  • Greece · Fibclot, Riastap
  • Croatia · Fibryga
  • Hungary · Fibclot, Fibryga
  • Ireland · Fibryga, Riastap
  • Iceland · Fibryga, Riastap
  • Italy · Fibriclotte, Fibryga
  • Lithuania · Fibryga
  • Luxembourg · Fibclot, Fibryga
  • Latvia · Fibryga
  • Malta · Fibryga, Riastap
  • Netherlands · Fibclot, Fibryga
  • Norway · Fibclot, Fibryga
  • Poland · Fibryga, Riastap
  • Portugal · Fibryga, Haemocomplettan
  • Romania · Fibryga, Haemocomplettan P
  • Sweden · Fibclot, Fibryga
  • Slovenia · Fibrema, Prufibry
  • Slovakia · Fibryga, Riastap

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e631222b-dfb0-4769-a480-e48548b96227
GET /v1/drugs/e631222b-dfb0-4769-a480-e48548b96227?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "3.0cm×2.5cm1枚",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "6349802X1020",
  "category": "外用薬",
  "price_yen": 10398.7,
  "generic_name": "フィブリノゲン配合剤",
  "product_name_jp": null,
  "therapeutic_class": "6349",
  "transitional_expiry": null
}

See everything about フィブリノゲン配合剤.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.